K. Höffken

7.4k total citations
186 papers, 5.4k citations indexed

About

K. Höffken is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K. Höffken has authored 186 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 34 papers in Molecular Biology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K. Höffken's work include Acute Myeloid Leukemia Research (20 papers), Cancer Treatment and Pharmacology (20 papers) and Colorectal Cancer Treatments and Studies (14 papers). K. Höffken is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Cancer Treatment and Pharmacology (20 papers) and Colorectal Cancer Treatments and Studies (14 papers). K. Höffken collaborates with scholars based in Germany, France and United States. K. Höffken's co-authors include Ulrich Wedding, R. Kath, Ludger Pientka, Herbert G. Sayer, Katharina Pachmann, H. Hirche, G. Riethmüller, Peter Buggisch, R. Pichlmayr and R. Raab and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

K. Höffken

158 papers receiving 5.2k citations

Peers

Countries citing papers authored by K. Höffken

Since Specialization

Citations

This map shows the geographic impact of K. Höffken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Höffken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Höffken more than expected).

Fields of papers citing papers by K. Höffken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Höffken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Höffken. The network helps show where K. Höffken may publish in the future.

Co-authorship network of co-authors of K. Höffken

This figure shows the co-authorship network connecting the top 25 collaborators of K. Höffken. A scholar is included among the top collaborators of K. Höffken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Höffken. K. Höffken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health-related quality of life in elderly cancer patients, elderly non-cancer patients and an elderly general population 2009 ·European Journal of Cancer Care ·(unknown), Cornelia Putz, Bernd Röhrig, K. Höffken, Ulrich Wedding	26
2	Current treatment options in dermatofibrosarcoma protuberans 2009 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Thomas Mentzel, K. Höffken	185
3	Diagnostik zur Stadieneinteilung beim Morbus Hodgkin: Vergleich von Laparotomie und nicht-invasiven Methoden 2008 ·DMW - Deutsche Medizinische Wochenschrift ·(unknown), K Donhuijsen, Martin K. Walz, (unknown), K. Höffken, (unknown)	0
4	Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study 2007 ·Journal of Clinical Oncology ·Michael Herold, Antje Haas, Stefanie Srock, Sabine Neser, Haifa Kathrin Al‐Ali, Andreas Neubauer, Gottfried Dölken, Ralph Naumann, Wolfgang Knauf, Mathias Freund, Robert Rohrberg, K. Höffken, Astrid Franke, T. H. Ittel, E. Kettner, Ursula Haak, Ulrich Mey, C. Klinkenstein, (unknown), (unknown)	371
5	Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy 2007 ·Acta Oncologica ·Ulrich Wedding, (unknown), Bernd Röhrig, Ludger Pientka, Heinrich Sauer, K. Höffken, Iris Maurer	46
6	Pharmacokinetics of oxaliplatin and non-hematological toxicity in metastatic gastrointestinal cancer patients treated with chronomodulated oxaliplatin, 5-FU and sodium folinate in a pilot investigat 2006 ·International Journal of Clinical Pharmacology and Therapeutics ·(unknown), Katrin Farker, Ulrich Wedding, (unknown), Marion Hippius, K. Höffken, Andrea Hoffmann	4
7	Acute Abdomen by Varicella Zoster Virus Induced Gastritis after Autologous Peripheral Blood Stem Cell Transplantation in a Patient with Non-Hodgkin’s Lymphoma 2006 ·Acta Haematologica ·Sebastian Scholl, Michael Hocke, K. Höffken, Herbert G. Sayer	14
8	Impairment in functional status and survival in patients with acute myeloid leukaemia 2006 ·Journal of Cancer Research and Clinical Oncology ·Ulrich Wedding, Bernd Röhrig, Almuth Klippstein, (unknown), Herbert G. Sayer, K. Höffken	84
9	Multicolor-FISH applied to resolve complex chromosomal changes in a case of T-ALL (FAB L2) 2006 ·Cytogenetic and Genome Research ·Hasmik Mkrtchyan, (unknown), (unknown), Ulrich Wedding, K. Höffken, Thomas Liehr, (unknown), Rouben Aroutiounian	3
10	Standardized quantification of circulating peripheral tumor cells from lung and breast cancer 2005 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Katharina Pachmann, Joachim H. Clement, Claus-Peter Schneider, (unknown), Oumar Camara, Ulrich Pachmann, K. Höffken	127
11	Safety and impact of donor‐type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch 2005 ·Transfusion ·Sebastian Scholl, (unknown), Lars‐Olof Mügge, Kristina Schilling, K. Höffken, Herbert G. Sayer	15
12	Pharmacokinetics of oxaliplatin during chronomodulated infusion in metastatic gastrointestinal cancer patients: A pilot investigation with preliminary results 2003 ·Experimental and Toxicologic Pathology ·(unknown), Ulrich Wedding, (unknown), K. Höffken, A Hoffmann	6
13	Zerebrale Metastasen bei kolorektalen Karzinomen 2002 ·Medizinische Klinik ·(unknown), R. Kath, S.M. Liesenfeld, (unknown), (unknown), (unknown), K. Höffken	7
14	Screening for people with diabetes mellitus for poor blood glucose control in an ophthalmological laser clinic 2001 ·Diabetes Research and Clinical Practice ·Ralf Schiel, Marcus Blum, Ulrich Müller, Sabine Köhler, (unknown), Jürgen Strobel, K. Höffken	3
15	Peptides in oncology III : somatostatin and LH-RH analogues 2000 ·Springer eBooks ·K. Höffken, R. Kath	1
16	A phase II study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric carcinoma 1998 ·Journal of Cancer Research and Clinical Oncology ·Martin Kristian Raida, R. Kath, (unknown), Georg Kähler, J. Scheele, K. Höffken	5
17	BRCA1 mutations in German breast-cancer families 1996 ·International Journal of Cancer ·Burkhard Jandrig, (unknown), Susanne Seitz, (unknown), Manuela Rodrigues Müller, (unknown), (unknown), Klaus Rohde, Peter M. Schlag, R. Kath, K. Höffken, Siegfried Scherneck	15
18	Peptides in oncology II : somatostatin analogues and bombesin antagonists 1993 ·Springer eBooks ·K. Höffken	2
19	High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen 1989 ·Cancer ·R. Becher, Antonius A. Miller, K. Höffken, (unknown), H. Hirche, Carl G. Schmidt	11
20	T lymphocyte-mediated graft--antigraft reactivity during graft-versus- host reaction in vitro 1984 ·Blood ·Harald von Melchner, K. Höffken	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact